News

The smaller market now envisioned for vepdegestrant has changed both companies’ stance on their original deal, leading to ...
A spokesperson confirmed the company plans to reduce its workforce by “less than 20%,” months after significantly lowering ...
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.
One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step ...